Mizuho Downgrades FibroGen to Neutral on 'Higher Risk And Uncertainty'
April 07, 2021 at 10:44 AM EDT
Mizuho analyst Difei Yang downgraded FibroGen to Neutral from Buy with a price target of $29, down from $72.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|